SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Axsome Therapeutics Price Target Cut to $247.00/Share From $251.00 by Morgan Stanley

Ratings actions from Benzinga: GMT) Axsome Therapeutics Is Maintained at Equal-Weight by Morgan StanleyRatings actions from Benzinga

AXSM

Related stories